Study of Dasatinib to Treat Philadelphia Positive Acute Lymphoblastic Leukemia

NCT01310010 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Lymphoblastic, Acute, Philadelphia-Positive

Interventions

DRUG: dasatinib

Sponsor

Grupo Espanol de trasplantes hematopoyeticos y terapia celular